Cue Health announced it entered into a cooperation agreement (the ?Cooperation Agreement?) with Tarsadia Investments (?Tarsadia?), and appointed Rishi Reddy to its board of directors (the ?Board?), effective immediately. Mr. Reddy is a Managing Director at Tarsadia, where he leads the firm?s venture and growth equity strategy. He was previously an Observer on Cue?s Board of Directors from April 2018 to September 2021.

In addition, the Board intends to commence a process to add an additional highly qualified, independent director to the Board. With the appointment of Mr. Reddy, Cue?s Board will expand to eight directors. The complete Cooperation Agreement between Cue and Tarsadia will be included as an exhibit to a Current Report on Form 8-K, which will be filed by Cue with the Securities and Exchange Commission.